The Klinique Medical Clinic PCL (BKK:KLINIQ) DeferredTaxAndRevenue: ฿516 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:KLINIQ The Klinique Medical Clinic PCL BKK:KLINIQ
90 GF Score
Price ฿28.00
GF Value ฿44.59
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is The Klinique Medical Clinic PCL DeferredTaxAndRevenue?

The Klinique Medical Clinic PCL BKK:KLINIQ +0.90% 90 DeferredTaxAndRevenue is ฿516 Mil as of Mar. 2026. GuruFocus rates BKK:KLINIQ with a GF Score™ of 90/100 and a GF Value™ of ฿44.59 (Significantly Undervalued). The stock has 6 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

The Klinique Medical Clinic PCL's current deferred tax and revenue for the quarter that ended in Mar. 2026 was ฿516 Mil.

The Klinique Medical Clinic PCL DeferredTaxAndRevenue Related Terms


The Klinique Medical Clinic PCL DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for The Klinique Medical Clinic PCL's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Klinique Medical Clinic PCL DeferredTaxAndRevenue Chart

The Klinique Medical Clinic PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial 288.76 403.31 400.82 405.76 466.42

The Klinique Medical Clinic PCL Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 435.92 438.53 446.74 466.42 516.26
BKK:KLINIQ
90GF Score
The Klinique Medical Clinic PCL BKK:KLINIQ
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of ฿516 Mil mean?
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a DeferredTaxAndRevenue of ฿516 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on The Klinique Medical Clinic PCL.
Is The Klinique Medical Clinic PCL's DeferredTaxAndRevenue too high?
The Klinique Medical Clinic PCL's current DeferredTaxAndRevenue is ฿516 Mil. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's DeferredTaxAndRevenue compare to ROL and SCI?
The Klinique Medical Clinic PCL's DeferredTaxAndRevenue of ฿516 Mil can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Personal Services company?
A good DeferredTaxAndRevenue depends on the Personal Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on The Klinique Medical Clinic PCL. The Klinique Medical Clinic PCL's current DeferredTaxAndRevenue is ฿516 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.59, compared to a current price of ฿28.00 — trading 37.2% below its estimated fair value. The current DeferredTaxAndRevenue is ฿516 Mil. The Klinique Medical Clinic PCL's overall GF Score™ is 90/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current DeferredTaxAndRevenue is ฿516 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?

Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued. The current stock price of ฿28.00 is trading 37.2% below its estimated GF Value™ of ฿44.59. GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.

Key valuation signals for BKK:KLINIQ:

  • DeferredTaxAndRevenue: ฿516 Mil
  • GF Value™: ฿44.59 vs. price of ฿28.00 (37.2% below fair value)
  • GF Score™: 90/100 with 6 warning signs

No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


The Klinique Medical Clinic PCL Business Description

Address New Petchburi Road, 2922/296-299, Charn Issara Tower 2, 27th Floor, Bangkapi, Huay Kwang, Bangkok, THA, 10310
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score

Get the complete analysis for BKK:KLINIQ

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿28.00
Price
฿44.59
GF Value